Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage regimes for the administration of an anti-CD25 ADC

Dosage regimes for the administration of an anti-CD25 ADC

US Patent 11426467 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage regimes for the administration of an anti-CD19 ADC2024
Combination therapy with an anti-CD25 antibody-drug conjugate2023
Combination therapy with an anti-CD25 antibody-drug conjugate2023
Dosage regimes for the administration of an anti-CD19 ADC2022
Dose and regimen for HDM2-p53 interaction inhibitors2021
GDF-15 as a haematological toxicity biomarker2021
Combination therapy with an anti-axl antibody-drug conjugate2020
Anti-tumor activity of CCI-779 in papillary renal cell cancer2014
Cut-point in PTEN protein expression that accurately identifies tumors and is pr2012
Combination therapy for the treatment of acute leukemia and myelodysplastic synd2010